ctrl K

Watchlist Price Alert

Trillium Therapeutics Inc... (TRIL)

NASDAQ: TRIL · Real-Time Price · USD

18.44

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Trillium Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	148K	124K	n/a	n/a	n/a
Cost of Revenue	147.85K	n/a	n/a	n/a	n/a
Gross Profit	148.00	124K	n/a	n/a	n/a
Operating Income	-61.45M	-35.44M	-34.51M	-32.6M	-25.09M
Interest Income	2.01M	614K	795.87K	574.15K	310.63K
Pretax Income	-59.24M	-41.59M	-31.19M	-35.85M	-26.35M
Net Income	-59.35M	-41.62M	-31.19M	-35.86M	-23.61M
Selling & General & Admin	36.26M	4.3M	2.63M	3.07M	2.93M
Research & Development	25.35M	25.3M	31.88M	29.53M	22.16M
Other Expenses	n/a	3.01M	n/a	-0.00	n/a
Operating Expenses	61.6M	32.61M	34.51M	32.6M	25.09M
Interest Expense	n/a	177K	31.57K	54.08K	48.63K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	61.6M	35.56M	34.51M	32.6M	25.09M
Income Tax Expense	102K	28K	5.87K	3.18K	-2.74M
Shares Outstanding (Basic)	83.75M	25.26M	13.91M	9.77M	7.82M
Shares Outstanding (Diluted)	83.75M	25.26M	13.91M	9.77M	7.82M
EPS (Basic)	-0.71	-1.65	-2.24	-3.67	-3.02
EPS (Diluted)	-0.71	-1.65	-2.24	-3.67	-3.02
EBITDA	-58.65M	-39.31M	-28.85M	-32.05M	-23.11M
EBIT	n/a	-41.42M	-31.16M	-35.8M	-26.3M
Depreciation & Amortization	591K	2.11M	2.31M	3.74M	3.19M